Unraveling the role of myeloid cells and metabolism in clinical progression of MS

B04

Myeloid cells play an increasingly recognized role in CNS autoimmune conditions such as multiple sclerosis (MS). However, mechanisms that drive disease progression from the relapsing-remitting to the progressive stage and that cause accumulating neurologic damage are far from being definitive. We identified dynamic modes of communication between neurons, CNS-localized myeloid cells and invading T lymphocytes in chronic neuroinflammation. Now, we will link a detailed understanding of the molecular pathways underlying this metabolic communication with a strong translational focus on disease progression. We could demonstrate that enhanced metabolic activity e.g. tissues like tumors or regenerating tissues after injury or during inflammatory processes, promotes an M2-like macrophage phenotype that is orchestrated by the transcription factor ICER in a G protein-coupled receptor (GPCR)- and cAMP-dependent manner (Bohn et al., 2018). We propose that the inflammatory response in the CNS, and accompanying acidification of the tissue, instructs a M2-like tissue repair phenotype in macrophages counteracting neurodegenerative processes and disease progression as an intrinsic defence mechanism of the CNS. To this end, we intend to answer these questions in our working plan:

    1. What is the role of G protein-coupled sensing of acidification and ICER expression in CNS inflammation and disease progression?
    2. What role does the role of ICER in metabolic reprogramming of macrophages and microglia play in CNS inflammation?
    3. What is the role of ICER and GPCR for disease progression in MS patients?


Sekine et al. Nature Immunology, 2018

 

Principal Investigators:

Prof. Dr. med. Stefan Bittner
Department of Neurology, Forschungszentrum Immuntherapie
Mainz
stefan.bittner@unimedizin-mainz.de

Univ.-Prof. Dr. rer. nat. Tobias Bopp
Institut für Immunologie Forschungszentrum Immuntherapie
Mainz
boppt@uni-mainz.de

News

Thu, 15/09/2022
Photo gallery: Inflammation & Imaging Symposium in the MIC building
Muenster. From September 12th to 14th scientists from Muenster University and their international guests discussed the latest developments in research on inflammation and the imaging of the immune system at the 2nd Inflammation & Imaging Symposium. The annual event is jointly organised by several research networks from Münster, among them the CRC/TRR 128 “Multiple Sclerosis”. […]...more
Tue, 28/06/2022
CRC Retreat in Münster
Muenster. After a long pause, more than 90 participants of the CRC joined in Muenster Factory Hotel to update on the latest developments. We heard the most recent on a selection of the CRC projects and there was also plenty of time for fruitful discussion and socializing in the evening....more
Mon, 23/05/2022
EU Research Council awards Lydia Sorokin Advanced Grant
Münster – The biochemist and Principal investigator of the CRC 128 Prof. Dr. Lydia Sorokin has received the coveted “Advanced Grant” awarded by the European Research Council (ERC). The funding of ca. 2.3 million euros enables the realisation of outstanding research projects. Lydia Sorokin heads the Institute for Physiological Chemistry and Pathobiochemistry at Muenster University. […]...more